LiFei Shang

Papers

1

Total Citations

14

H-Index

1

About

Dr. LiFei Shang is a clinical researcher whose work centers on refining surgical management strategies for gynecologic cancers, with a particular focus on endometrial cancer. Her most-cited study, a 2020 retrospective analysis, directly confronts a long-standing clinical debate: whether routine lymph node dissection is mandatory for all early-stage endometrial cancer patients. By challenging the conventional practice of universal lymphadenectomy, Dr. Shang’s work provides critical evidence to help surgeons identify which patients can safely avoid the procedure, thereby reducing unnecessary surgical morbidity. With 14 citations, this paper has already informed clinical decision-making and sparked further discussion on personalized surgical de-escalation. Dr. Shang’s contributions are especially valuable for oncologists and surgeons seeking to balance oncologic safety with quality of life, positioning her as a thoughtful voice in the movement toward more tailored, evidence-based care in gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study
14 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 16

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago